s6y
Company name or ticker
Search
CNS Pharmaceuticals, Inc.
3
Downs Christopher: Initial statement of beneficial ownership of securities
Filed
Wednesday, November 13, 2019
Period
Nov 13, 2019
Accession number
0001683168-19-003570
Documents
ownership.xml
3
POWER OF ATTORNEY
EX-24.1
On sec.gov
Filing index
All files
Complete submission text
SGML header